Sónia Sá Santos

Sónia Sá Santos

Auto-generated profile, based on publicly available information

Sónia Sá Santos

Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2016 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
SSSónia Sá Santos
Sónia Sá Santos
SSSara M. Santos
Sara M. Santos
APAntónia R. T. Pinto
Antónia R. T. Pinto
VRVasanthakumar G. Ramu
Vasanthakumar G. Ramu
MHMontserrat Heras
Montserrat Heras
MCMiguel Castanho
Miguel Castanho
Chronic brain ischemia is a prominent risk factor for neurological dysfunction and progression for dementias, including Alzheimer’s disease (AD). In rats, permanent bilateral common carotid artery occlusion (2VO) causes a progressive neurodegeneration in the hippocampus, learning deficits and memory loss as it occurs in AD. Kyotorphin (KTP) is an endogenous antinociceptive dipeptide whose role as neuromodulator/neuroprotector has been suggested. Recently, we designed two analgesic KTP-derivatives, KTP-amide (KTP-NH2) and KTP-NH2 linked to ibuprofen (IbKTP-NH2) to improve KTP brain targeting. This study investigated the effects of KTP-derivatives on cognitive/behavioral functions (motor/spatial memory/nociception) and hippocampal pathology of female rats in chronic cerebral hypoperfusion (2VO-rat model). 2VO-animals were treated with KTP-NH2 or IbKTP-NH2 for 7 days at weeks 2 and 5 post-surgery. After behavioral testing (week 6), coronal sections of hippocampus were H&E-stained or immunolabeled for the cellular markers GFAP (astrocytes) and NFL (neurons). Our findings show that KTP-derivatives, mainly IbKTP-NH2, enhanced cognitive impairment of 2VO-animals and prevented neuronal damage in hippocampal CA1 subfield, suggesting their potential usefulness for the treatment of dementia.

1 January 2003 in Biotechnology Progress
Verified
Journal Article
Closed access
PDF file
ACAna V. Carvalhal
Ana V. Carvalhal
SSSónia Sá Santos
Sónia Sá Santos
JCJosé Calado
José Calado
MHMatthias Haury
Matthias Haury
MOManuel D. Ortigueira
Manuel D. Ortigueira
Arresting cell growth and thus decreasing cell division potentially lessens the chance for genetic drift in the cell population; this would be of utmost importance for the consistent production of biopharmaceuticals during long periods. The drawback of the addition of well‐known synchronizing agents, such as chemotherapeutics, is that they cause a disproportionate accumulation of cellular constituents, leading to cell death. The use of compounds that are naturally synthesized by the cell, as is the case of nucleotides, nucleosides, and bases (Nt/Ns/B), is shown in this work to be a promising tool. The addition of purines and pyrimidines was tested using a CHO cell line producing the secreted form of the human placental alkaline phosphatase enzyme (SEAP). From the chemical alternatives tested, AMP was the most promising compound for protein production improvement; it reduced cell growth and maintained the culture with high cell viability for long periods, while increasing SEAP specific productivity 3‐fold. The use of CHO and BHK mammalian cells producing Factor VII and the use of a insect cell line (Sf9) showed that the effect of AMP addition seems to be independent of the r‐protein and cell line. With the addition of AMP, accumulation of cells at the S phase was accompanied by an increase of the protein specific productivity. Addition of known synchronizing drugs (aphidicolin and doxorubicin) and application of environmental cell growth arrest strategies (depletion of nutrients and byproduct accumulation) showed also to effectively arrest CHO cell growth. A careful look onto cell cycle distribution in the different scenarios created, shows whether it is important to consider r‐protein expression dependency upon cell cycle in process optimization and operation strategies.

13 January 2006 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
SSSónia Sá Santos
Sónia Sá Santos
GGGary E. Gibson
Gary E. Gibson
ACArthur J.L. Cooper
Arthur J.L. Cooper
TDTravis T. Denton
Travis T. Denton
CTCharles M. Thompson
Charles M. Thompson
USUrsula Sonnewald
Ursula Sonnewald

1 February 2008 in Neurochemistry International
Verified
Journal Article
Closed access
ATAna P. Teixeira
Ana P. Teixeira
SSSónia Sá Santos
Sónia Sá Santos
NCNuno Carinhas
Nuno Carinhas
Rui Manuel Freitas OliveiraRui Manuel Freitas Oliveira
Rui Manuel Freitas Oliveira
PAPaula M Alves
Paula M Alves

15 December 2004 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
SSSónia Sá Santos
Sónia Sá Santos
Luis FonsecaLuis Fonseca
Luis Fonseca
MMMiguel A.R. Monteiro
Miguel A.R. Monteiro
MOManuel D. Ortigueira
Manuel D. Ortigueira
PAPaula M Alves
Paula M Alves

6 April 2006 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
Ana CoroadinhaAna Coroadinha
Ana Coroadinha
PAPaula M Alves
Paula M Alves
SSS. Sá Santos
S. Sá Santos
PCP. E. Cruz
P. E. Cruz
OMO.-W. Merten
O.-W. Merten
MOManuel D. Ortigueira
Manuel D. Ortigueira